Product Information

LISDEXAMFETAMINE 70 MG CAPSULE is a generic product labeled by Granules Pharmaceuticals Inc., priced at $2.4378 per EA under NDC 70010021201. Its NADAC has been published 84 times since Apr 16, 2025.

FDA first approved this application on Jan 29, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 70 MG CAPSULE

LISDEXAMFETAMINE DIMESYLATE
$2.4378per EA
DEA Schedule CII

Strength

70 mg/1

NDC

70010021201

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA218987

FDA Approved

1/29/2025

TE Code

AB

On Market Since

1/29/2025

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 70 MG CAPSULE has been published 84 times since Apr 16, 2025, and over the history we have for it it has declined 57.6%. The table below summarizes its recorded NADAC range and movement.

Current price$2.4378 per EA
All-time high$5.7483 (Apr 16, 2025)
All-time low$2.4378 (Nov 18, 2026)
52-week high$3.1787
52-week low$2.4378
Median price$2.9750
Average price$3.3877
Largest weekly change-16.8% (Jun 18, 2025)
Weeks tracked84
Tracking sinceApr 16, 2025

Price History

1W

-6.4%

1M

-8.9%

3M

-11.7%

6M

-18.1%

1Y

-23.3%

3Y

N/A

5Y

N/A

All

-57.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 70 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 70 MG CAPSULE, manufactured by Granules Pharmaceuticals Inc., is $2.4378 per EA (NDC 70010021201), effective Nov 18, 2026.

How has the price of LISDEXAMFETAMINE 70 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 70 MG CAPSULE has declined 57.6%. It has been tracked across 84 weekly CMS publications since Apr 16, 2025.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 70 MG CAPSULE?

Since Apr 16, 2025, the NADAC for LISDEXAMFETAMINE 70 MG CAPSULE has ranged from a low of $2.4378 (Nov 18, 2026) to a high of $5.7483 (Apr 16, 2025), with a median of $2.9750 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 70 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 70 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures LISDEXAMFETAMINE 70 MG CAPSULE?

LISDEXAMFETAMINE 70 MG CAPSULE (NDC 70010021201) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.